Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SG301 in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome
NCT07087314Phase 2Recruiting
- Start
- Aug 2025
- Primary completion
- Jul 2028
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of SG301 in nephrotic syndrome. Started Aug 2025; status: recruiting.
02
Drugs
SG301
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT07087314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07087314.